Spots Global Cancer Trial Database for inflammatory
Every month we try and update this database with for inflammatory cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer | NCT01411943 | Breast Cancer | 21 Years - 81 Years | Virginia Commonwealth University | ||
| Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) | NCT02312167 | Cancer of Diges... Ovarian Cancer | confocal laser ... | 18 Years - | Institut Mutualiste Montsouris | |
| Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca | NCT00756132 | Locally Advance... Breast Cancer | 18 Years - 65 Years | University Health Network, Toronto | ||
| Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer | NCT01411943 | Breast Cancer | 21 Years - 81 Years | Virginia Commonwealth University | ||
| Neoadjuvant Treatment of Breast Cancer | NCT00254592 | Breast Cancer | Doxorubicin Cyclophosphamid... Carboplatin Nab-paclitaxel GM-CSF Trastuzumab Bevacizumab | 18 Years - | University of California, Irvine | |
| Neoadjuvant Treatment of Breast Cancer | NCT00254592 | Breast Cancer | Doxorubicin Cyclophosphamid... Carboplatin Nab-paclitaxel GM-CSF Trastuzumab Bevacizumab | 18 Years - | University of California, Irvine | |
| Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® | NCT03203837 | Hepatocellular ... | Plasma collecti... | 18 Years - | Northwestern University | |
| Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | NCT00558103 | Neoplasms, Brea... | lapatinib Pazopanib | 18 Years - | GlaxoSmithKline | |
| Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting | NCT00618657 | Breast Cancer HER2-negative B... HER2-positive B... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Carboplatin paclitaxel albu... bevacizumab trastuzumab magnetic resona... therapeutic con... | 21 Years - 90 Years | University of California, Irvine | |
| Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) | NCT02312167 | Cancer of Diges... Ovarian Cancer | confocal laser ... | 18 Years - | Institut Mutualiste Montsouris | |
| Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | NCT00558103 | Neoplasms, Brea... | lapatinib Pazopanib | 18 Years - | GlaxoSmithKline | |
| Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® | NCT03203837 | Hepatocellular ... | Plasma collecti... | 18 Years - | Northwestern University | |
| Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting | NCT00618657 | Breast Cancer HER2-negative B... HER2-positive B... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Carboplatin paclitaxel albu... bevacizumab trastuzumab magnetic resona... therapeutic con... | 21 Years - 90 Years | University of California, Irvine | |
| Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) | NCT02312167 | Cancer of Diges... Ovarian Cancer | confocal laser ... | 18 Years - | Institut Mutualiste Montsouris |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
